What is Northland Capmk’s Forecast for Arteris Q1 Earnings?

Arteris, Inc. (NASDAQ:AIPFree Report) – Investment analysts at Northland Capmk cut their Q1 2025 earnings estimates for Arteris in a research report issued on Wednesday, February 19th. Northland Capmk analyst G. Richard now expects that the company will earn ($0.21) per share for the quarter, down from their prior forecast of ($0.17). The consensus estimate for Arteris’ current full-year earnings is ($0.71) per share. Northland Capmk also issued estimates for Arteris’ Q2 2025 earnings at ($0.19) EPS, Q3 2025 earnings at ($0.17) EPS, Q4 2025 earnings at ($0.15) EPS, FY2025 earnings at ($0.71) EPS and FY2026 earnings at ($0.42) EPS.

Arteris (NASDAQ:AIPGet Free Report) last posted its earnings results on Tuesday, February 18th. The company reported ($0.19) EPS for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.08). The business had revenue of $15.49 million during the quarter, compared to the consensus estimate of $15.34 million. Arteris had a negative return on equity of 828.71% and a negative net margin of 58.27%.

A number of other analysts have also commented on AIP. Northland Securities lifted their price target on shares of Arteris from $14.00 to $16.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 19th. Rosenblatt Securities reaffirmed a “buy” rating and issued a $15.00 target price on shares of Arteris in a research report on Tuesday, February 18th.

View Our Latest Research Report on AIP

Arteris Price Performance

NASDAQ AIP opened at $9.32 on Monday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.16 and a current ratio of 1.17. The company has a market capitalization of $381.65 million, a price-to-earnings ratio of -10.71 and a beta of 1.18. The stock has a 50-day moving average of $10.52 and a 200 day moving average of $8.77. Arteris has a one year low of $5.76 and a one year high of $12.64.

Insider Transactions at Arteris

In related news, VP Paul L. Alpern sold 2,471 shares of the stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $11.41, for a total value of $28,194.11. Following the completion of the sale, the vice president now directly owns 64,930 shares of the company’s stock, valued at approximately $740,851.30. This represents a 3.67 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO K Charles Janac sold 17,856 shares of Arteris stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $10.12, for a total transaction of $180,702.72. Following the transaction, the chief executive officer now directly owns 10,287,435 shares in the company, valued at $104,108,842.20. This represents a 0.17 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 367,157 shares of company stock worth $3,828,388 in the last quarter. Company insiders own 33.70% of the company’s stock.

Institutional Trading of Arteris

A number of hedge funds and other institutional investors have recently modified their holdings of AIP. US Bancorp DE bought a new position in Arteris in the 3rd quarter worth $34,000. Quarry LP purchased a new stake in shares of Arteris during the fourth quarter worth about $46,000. R Squared Ltd purchased a new stake in shares of Arteris during the fourth quarter worth about $64,000. D. E. Shaw & Co. Inc. bought a new stake in Arteris during the 4th quarter valued at approximately $110,000. Finally, Price T Rowe Associates Inc. MD purchased a new position in Arteris in the 4th quarter worth approximately $117,000. 64.36% of the stock is owned by hedge funds and other institutional investors.

About Arteris

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Further Reading

Earnings History and Estimates for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.